Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Sana Biotechnology, Inc. (SANA)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-K10-K10-K
Revenues  357.40.00.00.0 
Cost of goods sold  0.00.00.00.0 
Gross profit  357.40.00.00.0 
            Gross margin  100.0%    
Selling, general and administrative   [+]71.650.428.321.8 
Research and development  285.9248.6132.999.6 
Other operating expenses  272.657.9124.919.8 
EBITDA   [+]-256.9-345.8-280.2-139.3 
            EBITDA margin  -71.9%    
Depreciation and amortization  15.611.15.91.8 
EBIT   [+]-272.6-356.9-286.1-141.2 
            EBIT margin  -76.3%    
Interest income  3.80.70.72.9 
Other income (expense), net  -0.70.30.10.0 
Pre-tax income  -269.5-355.9-285.3-138.3 
Income taxes  0.00.00.0-7.5 
            Tax rate  0.0%0.0%0.0%5.5% 
Net income  -269.5-355.9-285.3-130.8 
            Net margin  -75.4%    
   
Basic EPS   [+]($1.43)($2.14)($21.92)($26.67) 
Diluted EPS   [+]($1.43)($2.14)($21.92)($26.67) 
   
Shares outstanding (basic)   [+]188.3166.413.04.9 
Shares outstanding (diluted)   [+]188.3166.413.04.9 
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy